▶ 調査レポート

卵巣がん治療＆診断の世界市場 2019年版：種類別（手術、放射線療法、薬物治療）、用途別（病院、クリニック、その他）
• 英文タイトル：Global Therapies and Diagnostics for Ovarian Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。卵巣がん治療＆診断の世界市場 2019年版：種類別（手術、放射線療法、薬物治療）、用途別（病院、クリニック、その他） / Global Therapies and Diagnostics for Ovarian Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / C-GIR20G3061資料のイメージです。• レポートコード：C-GIR20G3061
• 出版社/出版日：GlobalInfoResearch / 2019年12月30日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、103ページ
• 納品方法：Eメール
• 産業分類：医療
• 販売価格（消費税別）
  Single User￥515,040 (USD3,480)▷ お問い合わせ
  Multi User￥772,560 (USD5,220)▷ お問い合わせ
  Corporate User￥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
「卵巣がん治療＆診断の世界市場2019年」は、グローバルにおける卵巣がん治療＆診断市場を展望するレポートです。卵巣がん治療＆診断のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。
・卵巣がん治療＆診断の市場概観
・卵巣がん治療＆診断の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・卵巣がん治療＆診断の企業別販売動向、市場シェア、市場集中度、競争動向
・卵巣がん治療＆診断の世界市場規模
・卵巣がん治療＆診断の北米市場分析（アメリカ、カナダ、メキシコ等）
・卵巣がん治療＆診断のアメリカ市場規模推移
・卵巣がん治療＆診断のカナダ市場規模推移
・卵巣がん治療＆診断のメキシコ市場規模推移
・卵巣がん治療＆診断のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・卵巣がん治療＆診断のドイツ市場規模推移
・卵巣がん治療＆診断のイギリス市場規模推移
・卵巣がん治療＆診断のロシア市場規模推移
・卵巣がん治療＆診断のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・卵巣がん治療＆診断の日本市場規模推移
・卵巣がん治療＆診断の中国市場規模推移
・卵巣がん治療＆診断の韓国市場規模推移
・卵巣がん治療＆診断のインド市場規模推移
・卵巣がん治療＆診断の東南アジア市場規模推移
・卵巣がん治療＆診断の南米市場分析（ブラジル、アルゼンチン等）
・卵巣がん治療＆診断の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・卵巣がん治療＆診断の種類別分析/販売量、売上、市場シェア（手術、放射線療法、薬物治療）
・卵巣がん治療＆診断の用途別分析/市場規模（病院、クリニック、その他）
・卵巣がん治療＆診断の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・卵巣がん治療＆診断の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Therapies and Diagnostics for Ovarian Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Therapies and Diagnostics for Ovarian Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Therapies and Diagnostics for Ovarian Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Therapies and Diagnostics for Ovarian Cancer market by product type and applications/end industries.

Market Segment by Companies, this report covers
Astra Zeneca
Merck
TESARO
Clovis Oncology
Janssen Pharmaceuticals
Myriad
Quest Diagnostics Inc
Celgene
AbbVie Inc
Novartis AG

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Surgery
Radiation Therapy
Drug Treatment

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

レポート目次

Table of Contents

1 Therapies and Diagnostics for Ovarian Cancer Market Overview
1.1 Product Overview and Scope of Therapies and Diagnostics for Ovarian Cancer
1.2 Classification of Therapies and Diagnostics for Ovarian Cancer by Types
1.2.1 Global Therapies and Diagnostics for Ovarian Cancer Revenue Comparison by Types (2019-2024)
1.2.2 Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Types in 2018
1.2.3 Surgery
1.2.4 Radiation Therapy
1.2.5 Drug Treatment
1.3 Global Therapies and Diagnostics for Ovarian Cancer Market by Application
1.3.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Therapies and Diagnostics for Ovarian Cancer Market by Regions
1.4.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Therapies and Diagnostics for Ovarian Cancer Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Therapies and Diagnostics for Ovarian Cancer Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Therapies and Diagnostics for Ovarian Cancer Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Therapies and Diagnostics for Ovarian Cancer Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Therapies and Diagnostics for Ovarian Cancer Status and Prospect (2014-2024)
1.5 Global Market Size of Therapies and Diagnostics for Ovarian Cancer (2014-2024)
2 Company Profiles
2.1 Astra Zeneca
2.1.1 Business Overview
2.1.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astra Zeneca Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck
2.2.1 Business Overview
2.2.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.3 TESARO
2.3.1 Business Overview
2.3.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 TESARO Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.4 Clovis Oncology
2.4.1 Business Overview
2.4.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Clovis Oncology Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.5 Janssen Pharmaceuticals
2.5.1 Business Overview
2.5.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Janssen Pharmaceuticals Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.6 Myriad
2.6.1 Business Overview
2.6.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Myriad Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.7 Quest Diagnostics Inc
2.7.1 Business Overview
2.7.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Quest Diagnostics Inc Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene
2.8.1 Business Overview
2.8.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.9 AbbVie Inc
2.9.1 Business Overview
2.9.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AbbVie Inc Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.10 Novartis AG
2.10.1 Business Overview
2.10.2 Therapies and Diagnostics for Ovarian Cancer Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis AG Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
3 Global Therapies and Diagnostics for Ovarian Cancer Market Competition, by Players
3.1 Global Therapies and Diagnostics for Ovarian Cancer Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Therapies and Diagnostics for Ovarian Cancer Players Market Share
3.2.2 Top 10 Therapies and Diagnostics for Ovarian Cancer Players Market Share
3.3 Market Competition Trend
4 Global Therapies and Diagnostics for Ovarian Cancer Market Size by Regions
4.1 Global Therapies and Diagnostics for Ovarian Cancer Revenue and Market Share by Regions
4.2 North America Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
4.3 Europe Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
4.5 South America Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
5 North America Therapies and Diagnostics for Ovarian Cancer Revenue by Countries
5.1 North America Therapies and Diagnostics for Ovarian Cancer Revenue by Countries (2014-2019)
5.2 USA Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
5.3 Canada Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
5.4 Mexico Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
6 Europe Therapies and Diagnostics for Ovarian Cancer Revenue by Countries
6.1 Europe Therapies and Diagnostics for Ovarian Cancer Revenue by Countries (2014-2019)
6.2 Germany Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
6.3 UK Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
6.4 France Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
6.5 Russia Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
6.6 Italy Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue by Countries
7.1 Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue by Countries (2014-2019)
7.2 China Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
7.3 Japan Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
7.4 Korea Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
7.5 India Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
8 South America Therapies and Diagnostics for Ovarian Cancer Revenue by Countries
8.1 South America Therapies and Diagnostics for Ovarian Cancer Revenue by Countries (2014-2019)
8.2 Brazil Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
8.3 Argentina Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
8.4 Colombia Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Therapies and Diagnostics for Ovarian Cancer by Countries
9.1 Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue by Countries (2014-2019)
9.2 Saudi Arabia Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
9.3 UAE Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
9.4 Egypt Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
9.5 Nigeria Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
9.6 South Africa Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
10 Global Therapies and Diagnostics for Ovarian Cancer Market Segment by Type
10.1 Global Therapies and Diagnostics for Ovarian Cancer Revenue and Market Share by Type (2014-2019)
10.2 Global Therapies and Diagnostics for Ovarian Cancer Market Forecast by Type (2019-2024)
10.3 Surgery Revenue Growth Rate (2014-2024)
10.4 Radiation Therapy Revenue Growth Rate (2014-2024)
10.5 Drug Treatment Revenue Growth Rate (2014-2024)
11 Global Therapies and Diagnostics for Ovarian Cancer Market Segment by Application
11.1 Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Application (2014-2019)
11.2 Therapies and Diagnostics for Ovarian Cancer Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Therapies and Diagnostics for Ovarian Cancer Market Size Forecast (2019-2024)
12.1 Global Therapies and Diagnostics for Ovarian Cancer Market Size Forecast (2019-2024)
12.2 Global Therapies and Diagnostics for Ovarian Cancer Market Forecast by Regions (2019-2024)
12.3 North America Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)
12.4 Europe Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)
12.6 South America Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Therapies and Diagnostics for Ovarian Cancer Picture
Table Product Specifications of Therapies and Diagnostics for Ovarian Cancer
Table Global Therapies and Diagnostics for Ovarian Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Types in 2018
Figure Surgery Picture
Figure Radiation Therapy Picture
Figure Drug Treatment Picture
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) by Application (2014-2024)
Figure Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Table Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table Astra Zeneca Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table Astra Zeneca Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table Merck Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table TESARO Basic Information, Manufacturing Base and Competitors
Table TESARO Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table TESARO Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Clovis Oncology Basic Information, Manufacturing Base and Competitors
Table Clovis Oncology Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table Clovis Oncology Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceuticals Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table Janssen Pharmaceuticals Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Myriad Basic Information, Manufacturing Base and Competitors
Table Myriad Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table Myriad Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Quest Diagnostics Inc Basic Information, Manufacturing Base and Competitors
Table Quest Diagnostics Inc Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table Quest Diagnostics Inc Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table Celgene Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table AbbVie Inc Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table AbbVie Inc Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Therapies and Diagnostics for Ovarian Cancer Type and Applications
Table Novartis AG Therapies and Diagnostics for Ovarian Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) by Players (2014-2019)
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Players (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Players in 2017
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Players in 2018
Figure Global Top 5 Players Therapies and Diagnostics for Ovarian Cancer Revenue Market Share in 2018
Figure Global Top 10 Players Therapies and Diagnostics for Ovarian Cancer Revenue Market Share in 2018
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) by Regions (2014-2019)
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Regions in 2018
Figure North America Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Europe Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure South America Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Table North America Therapies and Diagnostics for Ovarian Cancer Revenue by Countries (2014-2019)
Table North America Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries in 2018
Figure USA Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Canada Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Mexico Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Table Europe Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Europe Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries (2014-2019)
Figure Europe Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries in 2018
Figure Germany Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure UK Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure France Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Russia Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Italy Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries in 2018
Figure China Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Japan Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Korea Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure India Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Table South America Therapies and Diagnostics for Ovarian Cancer Revenue by Countries (2014-2019)
Table South America Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries in 2018
Figure Brazil Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Argentina Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Colombia Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue Market Share by Countries in 2018
Figure Saudi Arabia Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure UAE Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Egypt Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure Nigeria Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Figure South Africa Therapies and Diagnostics for Ovarian Cancer Revenue and Growth Rate (2014-2019)
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) by Type (2014-2019)
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Type (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Type (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Type in 2018
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue Forecast by Type (2019-2024)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Share Forecast by Type (2019-2024)
Figure Global Surgery Revenue Growth Rate (2014-2019)
Figure Global Radiation Therapy Revenue Growth Rate (2014-2019)
Figure Global Drug Treatment Revenue Growth Rate (2014-2019)
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue by Application (2014-2019)
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Application (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Application (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Share by Application in 2018
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue Forecast by Application (2019-2024)
Figure Global Therapies and Diagnostics for Ovarian Cancer Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Therapies and Diagnostics for Ovarian Cancer Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Therapies and Diagnostics for Ovarian Cancer Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)
Figure Europe Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)
Figure South America Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Therapies and Diagnostics for Ovarian Cancer Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介
  • 咽頭がん治療薬の世界市場 2019年版：種類別（手術、放射線療法、化学療法）、用途別（中咽頭がん、喉頭がん）
    Global Throat Cancer Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    C-GIR20G3063 2019年12月30日 103Pages
    「咽頭がん治療薬の世界市場2019年」は、グローバルにおける咽頭がん治療薬市場を展望するレポートです。咽頭がん治療薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）デー...
  • 世界のがん治療用遺伝子治療市場予測（～2024年）
    Global Gene Therapies for Cancer Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D3986 2019年9月18日 117Pages
    本調査レポートは、がん治療用遺伝子治療の世界市場について調べ、まとめました。種類別セグメントは、遺伝子誘導免疫療法、腫瘍溶解性ウイルス療法、遺伝子導入等、用途別セグメントは、病院、クリニック、その他等に区分しました。がん治療用遺伝子治療の世界市場概観、企業動向、企業別がん治療用遺伝子治療シェア、市場...
  • 膵臓がん診断装置の世界市場 2019年版：種類別（イメージング、腫瘍バイオマーカー、生検、その他）、用途別（病院、クリニック、その他）
    Global Pancreatic Cancer Diagnostic Devices Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    C-GIR20G2928 2019年12月30日 103Pages
    「膵臓がん診断装置の世界市場2019年」は、グローバルにおける膵臓がん診断装置市場を展望するレポートです。膵臓がん診断装置のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等...
  • 卵巣がん治療薬市場：世界及び中国市場分析・予測（～2024年）
    Ovarian Cancer Drugs Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT8788 2019年10月1日 149Pages
    「卵巣がん治療薬市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における卵巣がん治療薬市場について調査・分析したレポートで、卵巣がん治療薬の世界市場動向、市場規模、主要企業情報などが含まれています。
    ・卵巣がん治療薬産業の概要
    ・卵巣がん治療薬の製造技術分析...
  • 卵巣がん治療法市場：世界及び中国市場分析・予測（～2024年）
    Ovarian Cancer Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    C9OT4829 2019年10月8日 148Pages
    「卵巣がん治療法市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国における卵巣がん治療法市場について調査・分析したレポートで、卵巣がん治療法の世界市場動向、市場規模、主要企業情報などが含まれています。卵巣がん治療法のタイプ別には、PARP、PD-L1、血管新生阻害剤に分けて分析し、地...
  • 獣医感染症診断の世界市場 2019年版：種類別（免疫診断、分子診断、その他の技術）、用途別（ラボ、病院、クリニック、その他）
    Global Veterinary Infectious Disease Diagnostics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    C-GIR20G3089 2019年12月30日 123Pages
    「獣医感染症診断の世界市場2019年」は、グローバルにおける獣医感染症診断市場を展望するレポートです。獣医感染症診断のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）デー...
  • 血栓溶解療法の世界市場 2019年版：種類別（薬物治療、外科治療、その他の治療）、用途別（急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル閉塞、急性虚血性脳卒中）
    Global Thrombolytic Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    C-GIR20G3065 2019年12月30日 105Pages
    「血栓溶解療法の世界市場2019年」は、グローバルにおける血栓溶解療法市場を展望するレポートです。血栓溶解療法のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなど...
  • 世界の新がん診断市場予測（～2024年）
    Global Emerging Cancer Diagnostics Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
    B-GIR09D1244 2019年9月4日 116Pages
    本調査レポートは、新がん診断の世界市場について調べ、まとめました。種類別セグメントは、男性用、女性用等、用途別セグメントは、血液がん、前立腺がん、乳がん、肺がん、その他等に区分しました。新がん診断の世界市場概観、メーカー動向、メーカー別新がん診断シェア、市場規模推移、市場規模予測（2019年-202...
  • 世界の血液療法市場予測（～2024年）
    Global Hematology Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024
    B-GIR09D4011 2019年9月18日 122Pages
    本調査レポートは、血液療法の世界市場について調べ、まとめました。種類別セグメントは、血液学機器、血液学消耗品等、用途別セグメントは、診断研究所、病院および診療所、学術機関、その他等に区分しました。血液療法の世界市場概観、企業動向、企業別血液療法シェア、市場規模推移、市場規模予測（2019年-2024...
  • レボチロキシンナトリウムの世界市場 2019年版：種類別（甲状腺機能低下症、甲状腺腫、甲状腺がん、粘液水腫性昏睡）、用途別（病院、クリニック、その他）
    Global Levothyroxine Sodium Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    C-GIR20G1215 2019年12月30日 120Pages
    「レボチロキシンナトリウムの世界市場2019年」は、グローバルにおけるレボチロキシンナトリウム市場を展望するレポートです。レボチロキシンナトリウムのグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主...
  • 世界のがん治療用遺伝子治療市場予測（～2024年）世界のがん治療用遺伝子治療市場予測（～2024年） Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functi…
  • 卵巣がん治療薬市場：世界及び中国市場分析・予測（～2024年）卵巣がん治療薬市場：世界及び中国市場分析・予測（～2024年） Ovarian Cancer Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Ovarian Cancer Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ovarian Cancer Drugs manufac…
  • 卵巣がん治療法市場：世界及び中国市場分析・予測（～2024年）卵巣がん治療法市場：世界及び中国市場分析・予測（～2024年） Ovarian Cancer Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Ovarian Cancer Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ovarian Cancer…
  • 世界の新がん診断市場予測（～2024年）世界の新がん診断市場予測（～2024年） Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation. Scope of the Report: The global Emerging Cancer Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between …
  • 体外型がん診断市場：世界及び中国市場分析・予測（～2024年）体外型がん診断市場：世界及び中国市場分析・予測（～2024年） In Vitro Cancer Diagnostics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global In Vitro Cancer Diagnostics industry with a focus on the Chinese market. The report provides key statistics on the market status of the In Vitro Cance…